PerkinElmer, Inc. (PKI)
$18.99
-0.43 (-2.21%)
| CAPS Rating |
|
|---|---|
| Open | $18.74 |
| Previous Close | $19.42 |
| Daily Range | $18.74 - $19.21 |
| 52-Week Range | $10.88 - $21.09 |
| Market Cap | $2.22B |
| P/E Ratio | 25.56 |
| Dividend (Yield) | 0.28 (1.40%) |
| Volume | 416,313 |
| Average Daily Volume | 1,408,000 |
PKI
VS S&P 500 (SPY)
How do you think PKI will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
PKI Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
PKI News and Commentary
- Seeking Alpha on PerkinElmer Inc. – Ockham-RazorWire
- UPDATE 1-PerkinElmer profit falls but beats Street view – Reuters
- 4-Star Stocks on the Upswing – The Motley Fool
- 5 Superball Stocks – The Motley Fool
- The Truth Behind Buffett's Big Bet – The Motley Fool
- 4 More Companies Getting Taken Out – The Motley Fool
- PerkinElmer and ViaCell: A Bloody Good Deal? – The Motley Fool
- Get Ready for the Fall – The Motley Fool
- The Stocks the Funds Are Buying – The Motley Fool
- Picks and Shovels of Biotechnology – The Motley Fool
Related News and Articles
- 4-Star Stocks Poised to Pop: Sequenom – The Motley Fool
- How Do You Say 'Drug Development' in Mandarin? – The Motley Fool
- 3 Stocks Hitting High Notes – The Motley Fool
- Pharma Researchers Need a Cure – The Motley Fool
- The Waters Aren't Flowing. Yet. – The Motley Fool
- Ugly, but Still Built for Growth – The Motley Fool
- Taking the Drug Industry's Temperature – The Motley Fool
- 5 Cold Stocks Heating Up – The Motley Fool
RSS Headlines
Fool UK
